We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.2B
AUM Growth
+$642M
Cap. Flow
-$66.7M
Cap. Flow %
-0.59%
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97

Top Buys

Rank Stock Value
1
CEQP
Crestwood Equity Partners LP
CEQP
+$62.5M
2
EPD icon
Enterprise Products Partners
EPD
+$61.8M
3
CQP icon
Cheniere Energy
CQP
+$55.2M
4
WES icon
Western Midstream Partners
WES
+$47.5M
5
ALB icon
Albemarle
ALB
+$33.1M

Top Sells

Rank Stock Value
1
SHLX
Shell Midstream Partners, L.P.
SHLX
+$280M
2
XOM icon
ExxonMobil
XOM
+$28.2M
3
HPE icon
Hewlett Packard
HPE
+$27.6M
4
LMT icon
Lockheed Martin
LMT
+$27.5M
5
VLO icon
Valero Energy
VLO
+$27.3M

Sector Composition

Rank Sector Weight
1 Energy 63.96%
2 Technology 5.43%
3 Healthcare 4.22%
4 Consumer Discretionary 3.76%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1076
PMV Pharmaceuticals
PMVP
$66.1M
– –
-24,898
Closed -$296K
PPL
1077
PPL Corp
PPL
$27.3B
– –
-826,527
Closed -$21M
PTCT icon
1078
PTC Therapeutics
PTCT
$6.37B
– –
-39,030
Closed -$1.96M
QURE icon
1079
uniQure
QURE
$2.68B
– –
-25,499
Closed -$478K
RIGL icon
1080
Rigel Pharmaceuticals
RIGL
$680M
– –
-9,434
Closed -$111K
RLYB icon
1081
Rallybio
RLYB
$86.6M
– –
-2,197
Closed -$254K
RPTX
1082
DELISTED
Repare Therapeutics
RPTX
– –
-22,934
Closed -$278K
SWVL icon
1083
Swvl Holdings
SWVL
$14M
– –
-753
Closed -$16K
TCOM icon
1084
Trip.com Group
TCOM
$27.5B
– –
-10,294
Closed -$281K
TIL icon
1085
Instil Bio
TIL
$48.4M
– –
-3,541
Closed -$343K
TKC icon
1086
Turkcell
TKC
$4.84B
– –
-170,862
Closed -$454K
TNGX icon
1087
Tango Therapeutics
TNGX
$4.34B
– –
-48,071
Closed -$174K
TX icon
1088
Ternium
TX
$9.29B
– –
-17,789
Closed -$487K
UDR icon
1089
UDR
UDR
$12.9B
– –
-10,875
Closed -$454K
VICI icon
1090
VICI Properties
VICI
$29.4B
– –
-15,477
Closed -$462K
VRDN icon
1091
Viridian Therapeutics
VRDN
$2.13B
– –
-20,848
Closed -$428K
VXRT
1092
DELISTED
Vaxart
VXRT
– –
-69,043
Closed -$151K
WMS icon
1093
Advanced Drainage Systems
WMS
$10.9B
– –
-2,345
Closed -$292K
WPC icon
1094
W.P. Carey
WPC
$17.1B
– –
-6,178
Closed -$422K
VBIV
1095
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-4,699
Closed -$100K
LIAN
1096
DELISTED
LianBio American Depositary Shares
LIAN
– –
-58,490
Closed -$116K
KRTX
1097
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-18,271
Closed -$4.11M
ICVX
1098
DELISTED
Icosavax, Inc. Common Stock
ICVX
– –
-21,821
Closed -$69K
SI
1099
DELISTED
Silvergate Capital Corporation
SI
– –
-3,552
Closed -$268K
JNCE
1100
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-28,212
Closed -$66K
41 42 43
44
45

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ALPS Advisors held 1,116 positions worth $11.2B, up 6.1% from $10.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q4 2022 filing shows 76 new, 314 increased, 582 reduced and 97 closed positions. Its largest new stake was Albemarle: 124,308 shares worth $27M. The largest sale was Shell Midstream Partners, L.P., an estimated $280M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2022 buy was Albemarle: 124,308 shares worth $27M.
  • ALPS Advisors added most to Crestwood Equity Partners LP in Q4 2022, an estimated $62.5M increase.
  • ALPS Advisors's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $28.2M.
  • ALPS Advisors fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $280M.
  • ALPS Advisors's ten largest holdings make up 52% of its $11.2B portfolio in Q4 2022.
  • ALPS Advisors opened 76 new positions and closed 97 in Q4 2022.
  • ALPS Advisors's portfolio value rose 6.1% quarter-over-quarter to $11.2B.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.